A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts

被引:2
作者
Escudero-Ferruz, Paula [1 ,2 ]
Ontiveros, Neus [1 ,2 ]
Cano-Estrada, Claudia [1 ,2 ]
Sutcliffe, Diane J. [3 ]
Jinnah, H. A. [3 ,4 ,5 ]
Torres, Rosa J. [6 ,7 ]
Lopez, Jose M. [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Inst Neurociencies, Cerdanyola Del Valles 08193, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim, Fac Med, Cerdanyola Del Valles 08193, Barcelona, Spain
[3] Emory Univ, Dept Neurol, Sch Med, 101 Woodruff Circle,6305 Woodruff Mem Bldg, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA
[5] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA
[6] Inst Salud Carlos III ISCIII, Ctr Biomed Network Res Rare Dis, Madrid 28029, Spain
[7] La Paz Univ Hosp Hlth Res Inst, Dept Biochem, IdiPaz, Madrid 28046, Spain
关键词
Purine nucleotides; Folic acid; Lesch-Nyhan disease; ZMP; AICAR; Plasmax; ACTIVATED PROTEIN-KINASE; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; METABOLISM; BIOSYNTHESIS;
D O I
10.1186/s10020-023-00774-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundLesch-Nyhan disease (LND) is a severe neurological disorder caused by the genetic deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGprt), an enzyme involved in the salvage synthesis of purines. To compensate this deficiency, there is an acceleration of the de novo purine biosynthetic pathway. Most studies have failed to find any consistent abnormalities of purine nucleotides in cultured cells obtained from the patients. Recently, it has been shown that 5-aminoimidazole-4-carboxamide riboside 5MODIFIER LETTER PRIME-monophosphate (ZMP), an intermediate of the de novo pathway, accumulates in LND fibroblasts maintained with RPMI containing physiological levels (25 nM) of folic acid (FA), which strongly differs from FA levels of regular cell culture media (2200 nM). However, RPMI and other standard media contain non-physiological levels of many nutrients, having a great impact in cell metabolism that does not precisely recapitulate the in vivo behavior of cells.MethodsWe prepared a new culture medium containing physiological levels of all nutrients, including vitamins (Plasmax-PV), to study the potential alterations of LND fibroblasts that may have been masked by the usage of non-physiological media. We quantified ZMP accumulation under different culture conditions and evaluated the activity of two known ZMP-target proteins (AMPK and ADSL), the mRNA expression of the folate carrier SLC19A1, possible mitochondrial alterations and functional consequences in LND fibroblasts.ResultsLND fibroblasts maintained with Plasmax-PV show metabolic adaptations such a higher glycolytic capacity, increased expression of the folate carrier SCL19A1, and functional alterations such a decreased mitochondrial potential and reduced cell migration compared to controls. These alterations can be reverted with high levels of folic acid, suggesting that folic acid supplements might be a potential treatment for LND.ConclusionsA complete physiological cell culture medium reveals new alterations in Lesch-Nyhan disease. This work emphasizes the importance of using physiological cell culture conditions when studying a metabolic disorder.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] BRAIN PURINES IN A GENETIC MOUSE MODEL OF LESCH-NYHAN DISEASE
    JINNAH, HA
    PAGE, T
    FRIEDMANN, T
    JOURNAL OF NEUROCHEMISTRY, 1993, 60 (06) : 2036 - 2045
  • [22] Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease
    Fu, Rong
    Chen, Chung-Jen
    Jinnah, H. A.
    MOLECULAR GENETICS AND METABOLISM, 2014, 112 (04) : 280 - 285
  • [23] Description of the Molecular and Phenotypic Spectrum of Lesch-Nyhan Disease in Eight Chinese Patients
    Li, Lu
    Qiao, Xiaohui
    Liu, Fei
    Wang, Jingjing
    Shen, Huijun
    Fu, Haidong
    Mao, Jian-Hua
    FRONTIERS IN GENETICS, 2022, 13
  • [24] A human neuronal tissue culture model for Lesch-Nyhan disease
    Shirley, Thomas L.
    Lewers, J. Chris
    Egami, Kiyoshi
    Majumdar, Alokes
    Kelly, Mairead
    Ceballos-Picot, Irene
    Seidman, Michael M.
    Jinnah, H. A.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 841 - 853
  • [25] Skewed X inactivation in Lesch-Nyhan disease carrier females
    Torres, Rosa J.
    Puig, Juan G.
    JOURNAL OF HUMAN GENETICS, 2017, 62 (12) : 1079 - 1083
  • [26] New biomarkers for early diagnosis of Lesch-Nyhan disease revealed by metabolic analysis on a large cohort of patients
    Ceballos-Picot, Irene
    Le Dantec, Aurelia
    Brassier, Anais
    Jais, Jean-Philippe
    Ledroit, Morgan
    Cahu, Julie
    Ea, Hang-Korng
    Daignan-Fornier, Bertrand
    Pinson, Benoit
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [27] New biomarkers for early diagnosis of Lesch-Nyhan disease revealed by metabolic analysis on a large cohort of patients
    Irène Ceballos-Picot
    Aurélia Le Dantec
    Anaïs Brassier
    Jean-Philippe Jaïs
    Morgan Ledroit
    Julie Cahu
    Hang-Korng Ea
    Bertrand Daignan-Fornier
    Benoît Pinson
    Orphanet Journal of Rare Diseases, 10
  • [28] THE LESCH-NYHAN DISEASE - DESCRIPTION OF A CASE DIAGNOSED IN THE NEONATAL-PERIOD
    GUERRINI, P
    GARANI, GP
    SALVI, D
    TAMISARI, L
    MARI, R
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1993, 19 (03): : 291 - 295
  • [29] DOES THE BEHAVIOURAL PHENOTYPE OF LESCH-NYHAN DISEASE/LESCH NYHAN VARIANT DISORDER CORRELATE BEST WITH HPRT OR GPRT ENZYME ACTIVITY?
    Harris, J. C.
    Ward, R.
    Callon, W.
    Fu, R.
    Jinnah, H.
    Schretlen, D.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2015, 59 (09) : 792 - 792
  • [30] Unleashing the Power of Induced Pluripotent stem Cells in in vitro Modelling of Lesch-Nyhan Disease
    Javed, Sundas
    Fersini, Marco
    Bernardini, Giulia
    STEM CELL REVIEWS AND REPORTS, 2025, 21 (02) : 304 - 318